IN VITRO NEUROTECHNOLOGY
DefiningNeuro Translation.
/NEKS-EYE/
We build translational in vitro neural models that turn preclinical research into clinical insight — so the next generation of CNS therapies actually reach patients.
THE PROBLEM YOU KNOW
Your program will be judged by a human brain. Your evidence isn't built from one.
Most CNS candidates that reach human trials fail there — after years of work and most of the budget is already spent. Not for lack of ambition or rigor, but because the go / no-go evidence came from biology that isn't human.
The cost isn't only capital. It's the therapy that never reaches the patient waiting for it.
HOW WE WORK TOGETHER
We've built the models. You make the call.
NEXI exists so that the people advancing CNS therapies can see human biology before the clinic does. Three steps, no mystery.
Bring us the question
The translational uncertainty that will make or break your program — mechanism, efficacy, patient response.
We build the human circuit
Living human neural networks, matched in complexity to your question, measured functionally in real time.
You decide with human evidence
A clear, interpretable functional readout — so your go / no-go call rests on human biology, not a proxy for it.
OUR APPROACH
Models that mirror human biology — not just human cells in a dish.
Existing technologies lack the adequate complexity and format to answer the questions about the brain's cognitive function. By combining patient-derived neural systems with functional electrophysiology, we generate the kind of clinically meaningful data the field has been missing.
See how it works
WHAT CHANGES FOR YOU
Walk into your next go / no-go with the human answer in hand.
Human-relevant confidence
Signal grounded in human biology — not confidence borrowed from a rodent proxy.
Function, not just endpoints
Living networks measured as they respond — the dimension static assays can't see.
Answers that carry to the clinic
Evidence anchored to the decision in front of you and its clinical consequence.
Partner with the next generation of neuroscience.
Programs are stalling due to a lack of human relevant data, we help by generating translational signal that builds conviction in your asset. Whether you're advancing a CNS program or exploring novel mechanisms, our team is ready to help.